-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Cero Therapeutics Holdings, Inc. quarterly Depreciation history and growth rate from Q1 2023 to Q3 2024.
- Cero Therapeutics Holdings, Inc. Depreciation for the quarter ending September 30, 2024 was $114K, a 1.33% decline year-over-year.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)